Neuropsychiatric Lupus and Lupus Nephritis Successfully Treated with Combined IVIG and Rituximab: An Alternative to Standard of Care
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with unpredictable course and flares. The clinical manifestation can vary from mild to severe and life-threatening disease. Infection is the primary cause of mortality in hospitalized SLE patients. There is a paucity of evidence to s...
Saved in:
Main Authors: | Mohamed M. Cheikh, Abdullah K. Bahakim, Moayad K. Aljabri, Saad M. Alharthi, Sanad M. Alharthi, Abdullah K. Alsaeedi, Saad F. Alqahtani |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-01-01
|
Series: | Case Reports in Rheumatology |
Online Access: | http://dx.doi.org/10.1155/2022/5899188 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Classifying Lupus Nephritis: An Ongoing Story
by: Saba Kiremitci, et al.
Published: (2014-01-01) -
Dickkopf-1 Is a Biomarker for Systemic Lupus Erythematosus and Active Lupus Nephritis
by: Jing Xue, et al.
Published: (2017-01-01) -
Renal biopsy in lupus nephritis: To do or not to do?
by: Manish Rathi, et al.
Published: (2017-01-01) -
Endoplasmic Reticulum Stress in Systemic Lupus Erythematosus and Lupus Nephritis: Potential Therapeutic Target
by: Hui-Yuan Li, et al.
Published: (2023-01-01) -
SIRI and SII as potential biomarkers of disease activity and lupus nephritis in systemic lupus erythematosus
by: Chi-Hui Yang, et al.
Published: (2025-01-01)